首页 > 市场调查报告书 > 製药

生物製剂分子标靶治疗学

市场调查报告书

商品编码

1741169

中和抗体市场：按抗体类型、目标病毒、应用、最终用户、销售管道和地区划分

Neutralizing Antibody Market, By Antibody Type, By Target Virus, By Application, By End User, By Distribution Channel, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

中和抗体市场规模预计在 2025 年达到 2,439.3 亿美元，预计到 2032 年将达到 4,345.8 亿美元，2025 年至 2032 年的复合年增长率为 8.6%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	2439.3亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	8.60%	2032年价值预测	4345.8亿美元

中和抗体是先天免疫的重要组成部分，可由自然感染和疫苗接种诱导。这些抗体能够辨识病毒的特定部位，并阻止病毒与细胞结合和感染。抗体的特殊结构使其能够与病毒刺突蛋白上的受体结合域 (RBD) 结合，阻止其与宿主细胞受体结合，从而促进病毒进入细胞。

市场动态：

预计全球中和抗体市场将在预测期内快速成长。推动这一增长的主要因素之一是肝炎、爱滋病毒和结核病等感染疾病的高发生率。多种治疗性单株抗体的上市也是推动市场成长的因素之一。此外，采用先进的单株抗体开发技术也有望推动该市场的成长。然而，这些检测的高成本可能会限制其广泛应用，并阻碍市场成长。

本研究的主要特点

本报告对全球中和抗体市场进行了详细分析，并以 2024 年为基准年，给出了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球中和抗体市场的主要企业概况。
从本报告中获得的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球中和抗体市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过用于分析全球中和抗体市场的各种策略矩阵来做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 243.93 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.60%	2032 Value Projection:	USD 434.58 Bn

Neutralizing antibodies are a critical component of natural immunity and can be induced by both natural infection and vaccination. These antibodies recognize specific parts of the virus and prevent them from binding to and infecting cells. The antibodies' specialized structure allows them to bind to the receptor binding domain (RBD) on the viral spike protein, preventing it from engaging the host cell's receptor and facilitating virus entry into the cell.

Market Dynamics:

The global neutralizing antibody market is expected grow rapidly over the forecast period. One of the key drivers for this growth is the high prevalence of infectious diseases such as hepatitis, HIV, and tuberculosis. The availability of several therapeutic mAbs is another factor driving market growth. In addition, the introduction of advanced technologies for developing mAbs is expected to drive the growth of this market. However, the high cost of these tests can limit their adoption, thereby hindering market growth.

Key features of the study:

This report provides in-depth analysis of the global neutralizing antibody market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neutralizing antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Regeneron Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi SA, Roche Holding AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Takeda, Pharmaceutical Company Limited, Moderna, Inc., BioNTech SE, CSL Limited, and Sinovac Biotech Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neutralizing antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neutralizing antibody market

Neutralizing Antibody Market Detailed Segmentation:

By Antibody Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
By Target Virus:
- SARS-CoV-2 (COVID-19)
- HIV
- Influenza
- Ebola
- Zika
- Hepatitis C
- Others
By Application:
- Therapeutics
- Diagnostics
- Research and Development
By End User:
- Hospitals and Clinics
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical Companies
- Others
By Distribution Channel:
- Direct Sales to End-Users
- Distributors
- Online Retail
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Players
- Regeneron Pharmaceuticals, Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- GlaxoSmithKline plc
- Sanofi SA
- Roche Holding AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Moderna, Inc.
- BioNTech SE
- CSL Limited
- Sinovac Biotech Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Neutralizing Antibody, By Antibody Type
- Market Neutralizing Antibody, By Target Virus
- Market Neutralizing Antibody, By Application
- Market Neutralizing Antibody, By End User
- Market Neutralizing Antibody, By Distribution Channel
- Market Neutralizing Antibody, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- COVID-19 Pandemic
- Increasing Prevalence of Infectious Diseases
- Rising Incidence of Autoimmune Disorders
- Advancements in Biotechnology and Monoclonal Antibody Development
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Neutralizing Antibody Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Neutralizing Antibody Market, By Antibody Type, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Bn)
Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Bn)

6. Neutralizing Antibody Market, By Target Virus, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
SARS-CoV-2 (COVID-19)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Ebola
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Zika
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Hepatitis C
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)

7. Neutralizing Antibody Market, By Application, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)

8. Neutralizing Antibody Market, By End User, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)

9. Neutralizing Antibody Market, By Distribution Channel, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Direct Sales to End-Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Online Retail
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)

10. Neutralizing Antibody Market, By Region, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - GCC
  - Israel
  - North Africa
  - Central Africa
  - Rest of Middle East & Africa

11. Competitive Landscape

Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Moderna, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioNTech SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sinovac Biotech Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

12. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

中和抗体市场：按抗体类型、目标病毒、应用、最终用户、销售管道和地区划分